Dad speaks out after teen ordered banned testosterone booster online | Radio-Canada.ca

✦ New
CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
⚒ Cannabis News  |  CED Clinic
Adolescent HealthSupplementsEndocrineOnline SafetyTestosterone
Why This Matters

Online access to unregulated hormone-affecting substances poses serious risks for adolescent patients, particularly given ongoing brain development and hormonal changes during puberty. This highlights the need for clinicians to proactively discuss supplement safety and online purchasing risks with teenage patients and their families.

Clinical Summary

A teenager accessed a banned testosterone booster through online channels, prompting parental concern and regulatory attention. Unregulated testosterone boosters often contain undisclosed anabolic compounds, prohormones, or other substances that can disrupt normal endocrine function. Adolescents are particularly vulnerable to hormonal disruption during critical developmental periods. The case underscores ongoing challenges with supplement regulation and the accessibility of potentially harmful substances through e-commerce platforms.

Dr. Caplan’s Take

“I regularly see teenagers who’ve purchased ‘supplements’ online without understanding they’re essentially taking unregulated drugs. We need to normalize conversations about what our kids are ordering online just like we discuss what they’re exposed to at parties.”

Clinical Perspective
🧠 Clinicians should routinely inquire about supplement use, including online purchases, during adolescent visits. Parents need clear guidance on monitoring online purchases and understanding that ‘natural’ or ‘supplement’ labels don’t ensure safety. Consider discussing the risks of unregulated hormone-affecting substances as part of routine adolescent health education.

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

FAQ

What type of clinical content does this article contain?

This is a cannabis news article with notable clinical interest, classified as CED Clinical Relevance #70. It contains emerging findings or policy developments that warrant close monitoring by healthcare professionals.

What patient populations does this article focus on?

The article primarily focuses on adolescent health issues. This suggests the content discusses cannabis-related considerations specifically relevant to teenage patients and their healthcare needs.

What medical specialties are relevant to this content?

The article covers endocrine-related topics, indicating potential impacts on hormonal systems. Healthcare providers in endocrinology, adolescent medicine, and primary care should find this content particularly relevant.

Does this article address supplement-related concerns?

Yes, supplements are tagged as a key topic in this article. This suggests the content may discuss interactions, considerations, or comparisons between cannabis products and dietary supplements.

Are there online safety considerations discussed?

Online safety is identified as one of the article’s key themes. This likely addresses digital risks, online purchasing concerns, or internet-related safety issues relevant to cannabis use among adolescents.






{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Dad speaks out after teen ordered banned testosterone booster online | Radio-Canada.ca”, “url”: “https://ici.radio-canada.ca/rci/en/news/2242702/dad-speaks-out-after-teen-ordered-banned-testosterone-booster-online”, “datePublished”: “2026-03-31T19:18:27Z”, “about”: “dad speaks out after teen ordered”}